Supplement GMP seminars
This article was originally published in The Tan Sheet
Small businesses encouraged to attend an afternoon session of FDA's supplement GMP seminars, which will "provide small businesses an opportunity to ask questions about the proposed rule" and offer guidance on submitting comments, FDA says in March 28 Federal Register. Morning session, targeting all interested parties, will provide an overview of the proposed rule while specifically addressing consumer complaints, personnel, physical plant issues, utensils and equipment, holding and distributing, production and process controls, and recordkeeping. The East Coast meeting will take place at CFSAN's building in College Park, Md. April 29, while the West Coast meeting will convene May 6 at the Ronald V. Dellums Federal Building in Oakland, Calif. (1"The Tan Sheet" March 17, 2003, p. 8)...
You may also be interested in...
Amneal is close to a filed pipeline of three biosimilar products in the US, while furthering ambitions in the complex generics and 505(b)(2) space, management told the virtual J.P. Morgan Healthcare Conference.
Zydus Cadila is to begin testing a three-dose recombinant DNA vaccine candidate in Phase III Indian trials, which might enter late-stage development ahead of Inovio and AnGes. The company promised to provide 100-150 million doses by end of 2021 at the J.P. Morgan Conference, though adherence could be a roadblock.
Sun Pharma’s founder and MD shares with Scrip his views on some key big picture issues, including leveraging pandemic-related regulatory experience for urgently needed products, expectations in the US market, the outlook for M&A, and the potential of e-pharmacies in India.